Public Company News
HD Hyundai Heavy Industries Reaches Major Milestone in ITER Nuclear Fusion Project
* 'KOREA-ITER Fusion Day' held in France on the 22nd to celebrate completion of sector module assembly * HD Hyundai Heavy Industries proves mega-scale, high-precision manufacturing capabilities by producing 4 out of 9 vacuum vessel sectors * "As we take part in this major milestone for the w...
2026-07-23 08:40
2872
Samsung Biologics Reports Second Quarter 2026 Financial Results
* Recorded Q2'26 revenue of KRW 1,321 billion and operating profit of KRW 586 billion * Delivered stable business performance through continued disciplined execution * Expanded global presence while advancing innovation and future growth initiatives INCHEON, South Korea, July 23, 2026 /PRNe...
2026-07-23 07:03
3507
KDAN Open-Sources Core Products to Advance Enterprise AI Document Infrastructure and Data Sovereignty
ComPDF and DottedSign are now available on GitHub with self-hosted deployment options, enabling enterprises to validate, deploy and scale AI-powered document workflows while maintaining control of sensitive data IRVINE, Calif., July 22, 2026 /PRNewswire/ -- KDAN (TPEx: 7737), a global provider o...
2026-07-23 00:00
3307
HIGHWAY HOLDINGS SIGNS LOI TO LAUNCH MAJORITY-OWNED ENERGY STORAGE VENTURE WITH WOWTIGER BRAND OWNER HUAHU
Proposed Venture Combines Highway Holdings' Global Manufacturing and Commercial Platform with Huahu's Energy Storage Technology HONG KONG, July 22, 2026 /PRNewswire/ -- Highway Holdings Limited (Nasdaq: HIHO) today announced that it has signed a letter of intent ("LOI") with Guangdong Huahu New ...
2026-07-22 21:08
6447
Targeting the $100 Billion Market: Insilico Medicine Nominates AI-driven Novel PCC ISM9528 for Pain Management
* AI-Driven New Mechanism Discovery: Targeting an undisclosed novel mechanism empowered by PandaOmics, the PCC ISM9528 offers a potential first-in-class,brain -penetrant, non-opioid solution for pain management. * Superior Therapeutic Profile: In preclinical studies, ISM9528 demonstrated super...
2026-07-22 21:00
4378
Baidu Provides Update on Voluntary Conversion to Dual-Primary Listing on The Main Board of The Stock Exchange of Hong Kong Limited
BEIJING, July 22, 2026 /PRNewswire/ -- Baidu, Inc. ("Baidu" or the "Company") (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)), a leading AI company with strong Internet foundation, today provides an update on the Company's proposed voluntary conversion of its secondary listing st...
2026-07-22 19:30
3386
Sharon AI Appoints Anuj Goel as Chief Financial Officer
NEW YORK, July 22, 2026 /PRNewswire/ -- SharonAI Holdings Inc. (NASDAQ: SHAZ) and its subsidiaries ("Sharon AI" or "the Company"), a leading Australian Neocloud, today announced the appointment of Mr. Anuj Goel as incoming Chief Financial Officer, strengthening the company's executive leadership ...
2026-07-22 19:00
2355
LG Display presents vision of lifestyle transformation at K-Display 2026
SEOUL, South Korea, July 21, 2026 /PRNewswire/ -- LG Display, the world's leading innovator of display technologies, announced today its participation in K-Display 2026 at Seoul's COEX for three days from July 22, as the company seeks to accelerate its market differentiation based on next-generat...
2026-07-22 09:00
3050
China Pharma Holdings, Inc. Comments on Unusual Market Activity
HAIKOU, China, July 21, 2026 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma" or the "Company"), a fully-integrated specialty pharmaceuticals company in China, today announced that, in view of the unusual market activity in the common stock of China Pharma on July...
2026-07-22 04:00
3753
TOYO Expects U.S. Subsidiary to Be Eligible to Claim Section 45X Tax Credits for 2025
TOKYO, July 21, 2026 /PRNewswire/ -- TOYO Co., Ltd. (Nasdaq: TOYO; OTC: TOYWF) ("TOYO" or the "Company"), a solar manufacturing company, announced today that, based on a compliance analysis of production and sales activity at its Toyo Solar Texas facility conducted by a third-party tax advisory f...
2026-07-21 20:00
4126
Alebund Pharmaceuticals Announces First Participant Randomized and Dosed in Global Phase IIb Multi-Regional Clinical Trial of AP306 for Hyperphosphatemia
SHANGHAI, July 21, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; HKEX: 09637), a renal-focused biopharmaceutical company, today announced that the first participant has been randomized and dosed in the global Phase IIb multi-regional clinical trial of...
2026-07-21 19:00
2848
Tuya Smart Accelerates Physical AI Commercialization with Strategic Investment in Robopoet
HANGZHOU, China, July 21, 2026 /PRNewswire/ -- Tuya Smart (NYSE: TUYA, HKEX: 2391), a leading global AI cloud platform service provider, made a strategic investment in Robopoet's recently closed RMB 100 million pre-A financing round. The round also drew participation from existing backers Sequoia...
2026-07-21 18:28
2731
ESMO 2026 | Mabwell to Present Latest Clinical Data on Nectin-4-targeting ADC 9MW2821 for Triple Negative Breast Cancer in Oral Presentation
SHANGHAI, July 20, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, will present the latest clinical study results of its novel Nectin‑4‑targeting ADC, 9MW2821, for triple‑negative breast cancer in an oral ...
2026-07-21 11:50
2758
SuanNutra, Parent Company of Monteloeder and a Carbyne Equity Partners Portfolio Company, Expands Product Portfolio with Specialty Natural Ingredients Businesses from IFF
MADRID, July 20, 2026 /PRNewswire/ -- SuanNutra, the global science-backed ingredients group, today announced it has signed an agreement to acquire a portfolio of specialty natural ingredients businesses from IFF (NYSE: IFF). The transaction, backed by SuanNutra's majority shareholder Carbyne Equ...
2026-07-21 07:30
6332
WiMi Releases Resource-Efficient Quantum Convolutional Neural Network Based on QRAM, Accelerating the Practical Implementation of Large-Scale Image Classification Applications
BEIJING, July 20, 2026 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WiMi) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, announced the release of its latest independently developed achievement—a quantum convolutional neural network for effi...
2026-07-20 21:00
4739
Youlife Expands National Vocational Education Platform Through Strategic Partnership with Dazhou Technician College
SHANGHAI, July 20, 2026 /PRNewswire/ -- Youlife Group Inc. (NASDAQ: YOUL) ("Youlife" or the "Company"), a leading global blue-collar lifetime service platform, today announced that its vocational education brand, Tiankun Education, has entered into a comprehensive strategic cooperation agreement ...
2026-07-20 20:30
12049
YY Group Appoints Former Changi Airport Executive Ng Yansheng as Managing Director of YY Circle (SG) Pte. Ltd. to Drive Next Phase of Growth
SINGAPORE, July 20, 2026 /PRNewswire/ -- YY Group Holding Limited (NASDAQ: YYGH) ("YY Group" or the "Company"), a Singapore-based company providing manpower services and integrated facility management ("IFM") services, today announced the appointment of Ng Yansheng as the Managing Director of YY ...
2026-07-20 19:37
4743
Fast. Precise. Stable: Goodix GT9926 Redefines Gaming Touch
SHENZHEN, China, July 20, 2026 /PRNewswire/ -- When the match is on the line, it's not just about fast fingers. Touch performance matters too. Goodix's flexible OLED touch screen controller GT9926 delivers a major upgrade in gaming performance:   Goodix flexible OLED touch s...
2026-07-20 17:36
2828
Akeso Doses First Patient in Phase II Study of Novel TROP2/Nectin-4 Bispecific ADC (AK146D1) in Combination with Ivonescimab for Advanced NSCLC
HONG KONG, July 20, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that the first patient has been dosed in a Phase II clinical study (AK146D1-201) evaluating its internally developed TROP2/Nectin-4 bispecific antibody-drug conjugate (ADC), AK146D1, in combi...
2026-07-20 13:32
2849
Neuronata-R retains conditional approval in South Korea
South Korea's Ministry of Food and Drug Safety (MFDS) updates the stem cell therapy's approval in May 2026 — as the developer works to resume supply and build a U.S. research base SEOUL, South Korea, July 19, 2026 /PRNewswire/ -- Patients with amyotrophic lateral sclerosis (ALS) in South Korea w...
2026-07-20 07:00
2156
Week's Top Stories
Most Reposted
Visa Expands Support for its Clients and the Industry as Organisations Navigate New AI Era of Cybersecurity
[Picked up by 315 media titles]
2026-08-28 09:01Klook and Mastercard collaborate to enhance travelers' experiences across Asia Pacific
[Picked up by 313 media titles]
2026-08-27 10:25
AIMX Singapore 2026 Accelerates AI Deployment Through Catalysing Industry Innovation and Advancing Global Collaborations
[Picked up by 304 media titles]
2026-08-24 10:00
Henox and Nexusguard Announce Strategic Alliance at BATIC 2026 to Power and Protect the Next Generation of Digital Infrastructure
[Picked up by 297 media titles]
2026-08-25 10:00OGA 2026 Positions Kuala Lumpur as the Regional Marketplace for Southeast Asia's Energy Growth
[Picked up by 291 media titles]
2026-08-24 15:42
Most Read
AIMX Singapore 2026 Accelerates AI Deployment Through Catalysing Industry Innovation and Advancing Global Collaborations
2026-08-24 10:00
18207
OGA 2026 Positions Kuala Lumpur as the Regional Marketplace for Southeast Asia's Energy Growth
2026-08-24 15:42
18182
Rewarding Meetings Begin At Hyatt Regency Kuala Lumpur At KL Midtown
2026-08-25 07:00
16127
Klook and Mastercard collaborate to enhance travelers' experiences across Asia Pacific
2026-08-27 10:25
11830